Aesthetic Surgery Journal
Instructions to Authors
Editorial Office
Editor–in–Chief, Foad Nahai, MD
Associate Editor, Jeffrey M. Kenkel, MD
Aesthetic Surgery Journal
c/o Phaedra Cress
3200 Downwood Circle, Suite 640
Atlanta, GA 30327
Tel: (800) 364-2147 or (562) 799-2356 ext. 302
E-mail: journal@surgery.org
Disclaimer
Statements and opinions expressed in the articles and communications herein, including reader responses published in the Letters and Brief Communications section, are those of the author(s) and not necessarily those of the editors, the publisher, or the The Aesthetic Society, and the editors, the publisher, and the Aesthetic Society disclaim any responsibility or liability for such materials. The editors, the publisher, and the Aesthetic Society do not guarantee, warrant, or endorse any product or service advertised in this publication, nor do they guarantee any claim made by the manufacturer of such product or service.
#Publication Ethics
#Experimental Ethics
#Clinical Trials
#Self-Archiving Policy
#Drug Disclaimer
#Material Disclaimer
#CME Accreditation Statement
#Manuscript Submission
#Accepted Articles and Final Publication
#Embargos
#Corresponding Author Information
#License to Publish
#ORCID
#Permissions
#Consort Statement
#Article Types
#Article Type Descriptions
Publication Ethics
Authors should observe high standards with respect to publication ethics as set out by the Commission on Publication Ethics (COPE), the World Association of Medical Editors (WAME) and International Committee of Medical Journal Editors (ICMJE). Falsification or fabrication of data; plagiarism, including duplicate publication of the authors’ own work without proper citation; and misappropriation of work are all unacceptable practices. Any cases of ethical misconduct are treated very seriously and will be dealt with in accordance with COPE guidelines. The reviews of editors and peer reviewers will be considered confidential and should not be made publicly available without the express permission of the manuscript's authors and the journal's Editor in Chief. Predatory publishers and journals are a serious phenomenon and one that we follow very carefully. These are publisher and journals that purport to be bonafide but in fact are not. In some instances, real journal names are copied closely to confuse authors, prompting them to submit and publish in these fake journals. We receive continuous reports about outreach from predatory publishers and suggest if questions arise, readers and authors consult these two resources:
Cabell’s offers both whitelist and blacklist services and predatory reports to help authors discern legitimate journals and publishers. We suggest authors consult https://www2.cabells.com/about-predatory for guidance.
ThinkCheckSubmit website: this allows authors to confirm the legitimacy of journals and/or publishers by offering a detailed step-by-step checklist. This website is supported by: COPE, WAME, ICMJE, and OASPA and we encourage authors to follow these precautionary steps if they suspect predatory behavior.
ThinkCheckAttend website: this allows authors to confirm the legitimacy of academic conferences they may wish to attend, thereby avoiding predatory conferences.
WAME gives a useful overview of misconduct, using a slightly amended version of the US Office of Research Integrity definition of scientific misconduct and including these behaviors:
Falsification of data: ranges from fabrication to deceptive reporting of findings and omission of conflicting data, or willful suppression and/or distortion of data.
Plagiarism: The appropriation of the language, ideas or thoughts of another without crediting their true source and representation of them as one’s own original work.
Improprieties of authorship: improper assignment of credit, such as excluding others, misrepresentation of the same material as original in more than one publication, inclusion of individuals as authors who have not made a definite contribution to the work published or submission of multi-authored publications without the concurrence of all authors.
Misappropriation of the ideas of others: an important aspect of scholarly activity is the exchange of ideas among colleagues. Scholars can acquire novel ideas from others during the process of reviewing grant applications and manuscripts. However, improper use of such information can constitute fraud. Wholesale appropriation of such material constitutes misconduct.
Violation of generally accepted research practices: serious deviation from accepted practices in proposing or carrying out research, improper manipulation of experiments to obtain biased results, deceptive statistical or analytical manipulations, or improper reporting of results.
Material failure to comply with legislative and regulatory requirements affecting research: including but not limited to serious or substantial, repeated, willful violations of applicable local regulations and law involving the use of funds, care of animals, human subjects, investigational drugs, recombinant products, new devices, or radioactive, biological or chemical materials.
Inappropriate behavior in relation to misconduct: this includes unfounded or knowingly false accusations of misconduct, failure to report known or suspected misconduct, withholding of information relevant to a claim or misconduct and retaliation against persons involved in the allegation or investigation.
Many journals, including the Aesthetic Surgery Journal, also include redundant publication and duplicate publication, lack of declaration of competing interests and of funding/sponsorship, and other failures of transparency to be forms of misconduct.
Dealing with allegations of misconduct
We take seriously all possible misconduct. If an editor has concerns that a submitted article describes something that might be considered to constitute misconduct in research, publication or professional behavior, we will discuss the case in confidence among our editorial team. The Editor in Chief, editorial staff and/or the ASJ Ethics Committee will review all instances on a case-by-case basis.
If the case cannot be resolved by discussion with the author(s) and the Editor still has concerns, the case may be reported to the appropriate authorities. If, during the course of reviewing an article, an editor is alerted to possible problems (for example, fraudulent data) in another publication, the editor should immediately alert the Editor-in-Chief here: journal@surgery.org.
Readers that suspect misconduct in a published article are encouraged to report this to the Editor-in-Chief here: journal@surgery.org. Cases of research publication misconduct may be referred to COPE in an anonymized format if further guidance is required.
Authorship
All authors listed on the manuscript should have contributed significantly to the design or implementation of the experiment or the analysis and interpretation of the data. All authors should have been involved in the writing of the manuscript at the draft and any revision stages and have read and approved the final version. Any other individuals who contributed to the experiment or the writing of the manuscript should be listed in the Acknowledgment section. Two first co-authors may be included and this may be denoted in the Acknowledgement section.
Corresponding author
Only one corresponding author is permitted for each manuscript. Only the first author entered in the system will receive automated messages, such as editors’ decisions and page proofs.
Authorship Requirements
For guidelines on authorship, please refer to the Uniform Requirements for Manuscripts Submitted to Biomedical Journals [PDF], formulated by the International Committee of Medical Journal Editors. The cover letter should state that all authors have seen and approved the manuscript.
Affiliations
Author affiliations and corresponding author information should be limited to your current or most important affiliation, which may include academic university affiliations or private practice name. Only one affiliation per author is permissible. If more than one is received, the first will be used. Please include your title (eg, Clinical Professor, Chair of the Department of Plastic Surgery, Medical Student, Resident/Fellow, etc.). When all authors work at the same university, the affiliation will be listed as: “From the Division/Department of, University, City, State.” Doctors in private practice will be listed as: “Dr. Jones is in private practice in city, state, country”
Originality
By submitting your manuscript to the journal, it is understood that it is an original manuscript, is unpublished work, and is not under consideration elsewhere.
Authorship and "Umbrella" groups
Many large collaborative studies are organized under a group name that represents all the participants. All articles must have at least one named individual as author. Authors who wish to acknowledge the umbrella group from which the data originate should list the authors of the article, followed by "on behalf of the [GROUP NAME]". The members of the group should be listed individually in the acknowledgments section, and if correctly presented will ultimately be listed in Medline as 'collaborators'.
Conflict of interest
At the point of submission, each author should reveal any financial interests or connections, direct or indirect, or other situations that might raise the question of bias in the work reported or the conclusions, implications, or opinions stated--including pertinent commercial or other sources of funding for the individual authors or for the associated departments or organizations, personal relationships, or direct academic competition. If an author is an employee of a company (or consults/lectures for, owns stock in, receives royalties for, is on the board of directors for, etc.) who’s product is being discussed in the article, this must be disclosed.
If the manuscript is published, Conflict of Interest information, including if none was declared, will be communicated in a statement in the published paper.
Any changes made to the list of conflicts after the paper is accepted must be submitted in writing, signed by the appropriate authors (that is, the corresponding author and the author for whom the conflict exists), to the Aesthetic Surgery Journal editorial office.
Experimental Ethics
Human subjects
For manuscripts that describe experimental studies on human beings, the author must state in the manuscript that he or she has obtained institutional review board (IRB) approval and informed consent from patients. Verification of informed consent for every patient must be uploaded with your submission to verify consent was received. In those cases where IRB approval is unavailable, the guidelines of the Department of Health and Human Services (DHHS) Regulations for the Protection of Human Subjects or the Belmont Report must be followed. For international authors, the guidelines of the Declaration of Helsinki must be followed. Copies of these documents are available online at the following sites:
DHHS Regulations
Belmont Report
Declaration of Helsinki
Animal experiments
For manuscripts that describe animal studies, the US Public Health Service Policy on Humane Care and Use of Laboratory Animals must be followed. Prior to submitting a manuscript, authors must read and agree to the Ethics in Publishing statement posted on the Journal website. This statement reflects key principles outlined in the International Committee of Medical Journal Editors' "Uniform Requirements for Manuscripts" and the Council of Science Editors' "Editorial Policy Statement."
Clinical Trials
In accordance with the Clinical Trial Registration Statement from the International Committee of Medical Journal Editors (ICMJE), all clinical trials published in the journal must be registered in a public trials registry at or before the onset of participant enrollment.
The registry must be accessible to the public at no charge, searchable, open to all prospective registrants, managed by a not-for-profit organization, and include all the necessary information as specified by the ICMJE. A list of recommended registries can be found on the ICMJE website. Results posted in the same clinical trials registry in which the primary registration resides will not be considered prior publication if they are presented in the form of a brief abstract (<500 words or less) or a table.
Authors are requested to provide the exact URL and unique identification number for the trial registration at the time of submission. This information will be published in the article, and we ask that you include the URL and identification number on the title page of your manuscript.
Self-Archiving Policy
The published journal article cannot be shared publicly, for example on ResearchGate, Academia.edu, or other academic social networking sites, to ensure the sustainability of peer-reviewed research in journal publications.
OUP’s self-archiving policy sets out the ways in which OUP journal authors can self-archive versions of their work on their own webpages, on institutional webpages, and in other repositories.
For information about this journal's policy, please visit our Author Self-Archiving policy page.
Drug Disclaimer
The mention of trade names or commercial products or organizations and the inclusion of advertisements in Aesthetic Surgery Journal does not imply endorsement by the Society, the editors, the editorial board, Oxford University Press, or the organization to which the authors are affiliated. The editors and publishers have taken all reasonable precautions to verify drug names and doses, the results of experimental work, and clinical findings published in Aesthetic Surgery Journal. The ultimate responsibility for the use and dosage of drugs mentioned in Aesthetic Surgery Journal and in the interpretation of published material lies with the medical practitioner, and the editors and publishers cannot accept liability for damages arising from any errors or omissions in Aesthetic Surgery Journal. Please inform the editors of any errors.
Material Disclaimer
The opinions expressed in Aesthetic Surgery Journal are those of the authors and contributors and do not necessarily reflect those of the Society (The Aesthetic Society), the editors, the editorial board, the publisher (Oxford University Press), or the organization with which the authors are affiliated. Level of Evidence (LOE) categories presented in Aesthetic Surgery Journal reflect a judgment regarding the strength of the evidence that was available to our authors before publication and the relevant importance of benefits. We promote the use of evidence-based medicine in medical research and within Aesthetic Surgery Journal. The LOE for qualified articles will be reviewed by the Editor–in-Chief, the EBM Hub Co-Editors, and/or technical experts as appropriate. We use the LOE scale and classify levels as Therapeutic, Risk, or Diagnostic. We trust that our authors will confirm the accuracy of information presented to describe generally accepted practices. Other professionals in the field may have varying opinions; therefore, and because of advances in medical research we strongly suggest that readers personally verify specified treatments and drugs including manufacturers' guidance. It is the reader's responsibility to render their own professional decisions, and to appropriately advise and treat their own patients.
The Aesthetic Surgery Journal endeavors to provide accurate and up-to-date information, but we do not warrant that it is, nor do our licensors who supply certain content linked to or otherwise accessible from our content. We do not advocate or endorse the use of any drug or therapy contained within, nor does it diagnose patients. Information published is provided on an ‘as is' (?) basis and to the fullest extent permitted by law, the Journal and its licensors assume no responsibility for any aspect of healthcare administered with the aid of this information or any other use of this information.
……
更多详情：
https://academic.oup.com/asj/pages/General_Instructions
